Stories from George Clinical Staff Conducting a Major COVID-19 Trial at the Height of Worldwide Lockdowns

Stories from George Clinical Staff Conducting a Major COVID-19 Trial at the Height of Worldwide Lockdowns

“Extraordinary achievements under unprecedented conditions,” is how Chief Medical Officer Maria Ali describes the reality of a George Clinical team drawing on proven working models, established global relationships and an unflinching dedication to implement a clinical trial in a matter of weeks during a global pandemic.   Getting the job done despite extreme conditions The […]

Read More

January 21st, 2021

Conducting Major COVID-19 Trial at Height of Worldwide Lockdown: Extraordinary Achievements Under Unprecedented Conditions

George Clinical teams draw on proven working models, established global relationships and unflinching dedication to implement clinical trial in a matter of weeks. In the dark times of global COVID-19 lockdowns, scientists and healthcare workers pressed forward in their mission of caring for and protecting the sick, particularly those who were contracting COVID-19. The global […]

Read More

January 21st, 2021

Oncologist Herbert Loong Joins George Clinical Scientific Leadership

OVERLAND PARK, Ks., January 15, 2021 – Herbert Loong, MBBS, PDipMDPath, MRCP (UK), FRCP Edin, FHKCP, FHKAM (Medicine), an oncologist and clinical researcher based in Hong Kong, has joined the scientific leadership of George Clinical, a global scientifically-backed clinical research organization.  Dr. Loong holds conjoint appointments of Clinical Assistant Professor in the department of clinical […]

Read More

January 15th, 2021

Race Oncology Breast Cancer Clinical Trial Initiated with George Clinical

Race Oncology announced recently that it has appointed George Clinical to scope and cost a proof-of-concept Phase I/II breast cancer clinical trial of Bisantrene in combination with cyclophosphamide. This program will enable the Race Oncology Board to make a fully informed and costed decision on this important clinical pathway before expending significant shareholder funds. Bisantrene […]

Read More

December 12th, 2020

George Clinical Attends DIA China

George Clinical team members recently participated in the 12th Annual DIA China Meeting, the largest Chinese event in the life sciences industry. The conference is designed to “foster the international exchange of actionable insights to improve health globally through the advancement of lifesaving medicines and technologies in the APAC region.” Around 3,000 pharmaceutical R&D professionals […]

Read More

November 13th, 2020

Abby Abraham Joins George Clinical to lead Global Data Science and head India Business

OVERLAND PARK, Ks., October 8, 2020 – Abby Abraham, a veteran clinical researcher and data science lead, has joined George Clinical, a global scientifically-backed clinical research organization, to head up the organization’s Global Data Science team and operations in India.  Abraham, a progressive clinical research professional passionate about altering the existing clinical research execution paradigm […]

Read More

October 10th, 2020

Cancer Specialist Dipti Talaulikar Joins George Clinical Scientific Leadership

OVERLAND PARK, Ks., September 21, 2020 – Dipti Talaulikar, MBBS, PhD, a clinician and researcher with extensive involvement in hematology, has joined George Clinical, a global scientifically-backed clinical research organization, as a member of the organization’s scientific leadership.  In addition to her new role as a scientific leader with George Clinical, Dr. Talaulikar is also […]

Read More

September 22nd, 2020

MEDLAB and George Clinical Team up for NANABIS™ PHASE III TRIAL

Medlab Clinical, a company with a portfolio of novel drug candidates including cannabinoids and nutraceuticals, enhanced by its drug delivery platform and used for the treatment of chronic pain and disease, announced that it has signed an agreement with George Clinical to provide clinical services support for Medlab’s upcoming NanaBis™ Phase III trials. The Phase […]

Read More

September 19th, 2020

George Clinical Adds CRO Business Development and Operations Veteran to Lead Efforts in China

OVERLAND PARK, Ks., September 2, 2020 – George Clinical, a global scientifically-backed clinical research organization, has expanded the organization’s team in China with the addition of Dr. Zhenfei Yin in the role of Country Head and Regional Head of Project Operations.  Zhenfei will be responsible for leading operations teams across China. Zhenfei brings nearly a […]

Read More

September 2nd, 2020

George Clinical Scientific Leadership Adds Hypertension and Cardiovascular Researcher Professor Alta Schutte

OVERLAND PARK, Ks., August 18, 2020 – Alta Schutte, Ph.D., an expert researcher in hypertension and cardiovascular disease has joined George Clinical, a global scientifically-backed clinical research organization, as a member of the organization’s scientific leadership team. Schutte serves as Principal Theme Lead of Cardiac, Vascular and Metabolic Medicine in the faculty of medicine at […]

Read More

August 18th, 2020
Sign Up For Our Newsletter

required
required
required
required
I wish to subscribe to George Clinical communications.
required

Add George Clinical to your network